Journal of Proteomics · 2010 · 141 citations · 48 references
Life SciencesNeurologyNeuroscienceClinical NeuroscienceNeurodegenerationNeuroimmunologyBiomarkers Of NeurodegenerationCerebrospinal Fluid BiomarkersDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisNeurodegenerative DiseasesClinical Laboratory EvaluationCsf-to-blood Biomarker RatiosNeuroinflammatory Disease Biomarkers
48
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text